SEC Company Response from BioNTech SE (BNTX) (CIK 0001776985) (BNTX) — Mar 31, 2020
BioNTech SE (BNTX) (CIK 0001776985)
Date: March 31, 2020 · CIK: 0001776985 · Accession: 0001193125-20-093026
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237515
Letter
SEC Acceleration Request
BioNTech SE
An der Goldgrube 12
D-55131 Mainz
Germany
March 31, 2020
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3561
Attn: Paul Fischer
Re:
BioNTech SE
Registration Statement on Form F-4
Filed March 31, 2020
File No. 333-237515
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), BioNTech SE (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement on Form F-4 (the “Registration Statement”) be accelerated by the U.S. Securities and Exchange Commission so that the Registration Statement will be declared effective under the Securities Act at 4:00 p.m. Eastern Time on April 2, 2020, or as soon thereafter as is practicable, or such other time as the Company or its counsel, Covington & Burling LLP, may request by telephone that such Registration Statement be declared effective.
We respectfully request that we be notified of such effectiveness by a telephone call to Brian K. Rosenzweig of Covington & Burling LLP at (212) 841-1108 and that such effectiveness also be confirmed in writing.
Respectfully,
BioNTech SE
Show Raw Text
CORRESP 1 filename1.htm SEC Acceleration Request BioNTech SE An der Goldgrube 12 D-55131 Mainz Germany March 31, 2020 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3561 Attn: Paul Fischer Re: BioNTech SE Registration Statement on Form F-4 Filed March 31, 2020 File No. 333-237515 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), BioNTech SE (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement on Form F-4 (the “Registration Statement”) be accelerated by the U.S. Securities and Exchange Commission so that the Registration Statement will be declared effective under the Securities Act at 4:00 p.m. Eastern Time on April 2, 2020, or as soon thereafter as is practicable, or such other time as the Company or its counsel, Covington & Burling LLP, may request by telephone that such Registration Statement be declared effective. We respectfully request that we be notified of such effectiveness by a telephone call to Brian K. Rosenzweig of Covington & Burling LLP at (212) 841-1108 and that such effectiveness also be confirmed in writing. Respectfully, BioNTech SE By: /s/ Prof. Ugur Sahin, M.D. Name: Prof. Ugur Sahin, M.D. Title: Chief Executive Officer cc: Brian K. Rosenzweig, Covington & Burling LLP